Sedative and hypnotic addiction treatment helps people address medication or substance use that has become difficult to control and harmful to their health, safety, relationships, or daily functioning. Sedatives slow activity within the central nervous system, while hypnotics are generally used to help initiate or maintain sleep. Many medications have both sedative and hypnotic effects, which is why these terms are frequently grouped together in clinical care. Rainbow Hill Recovery provides structured outpatient treatment in Los Angeles for adults who are medically stable and need support addressing sedative use, mental health symptoms, trauma, and continuing recovery.
Sedative and hypnotic medications are central nervous system depressants that reduce brain activity and may produce relaxation, drowsiness, reduced anxiety, impaired coordination, or sleep. Healthcare professionals may prescribe these medications for insomnia, panic attacks, anxiety disorders, seizures, muscle spasms, or other specific medical concerns. Their legitimate medical uses do not eliminate the possibility of physical dependence, misuse, unsafe interactions, or addiction. The effects and risks depend on the medication, dosage, treatment duration, other substances being used, and the person’s physical and mental health.
Common sedative-hypnotic medications include benzodiazepines such as alprazolam, clonazepam, diazepam, lorazepam, and temazepam. The category also includes nonbenzodiazepine sleep medications, often called Z-drugs, such as zolpidem, eszopiclone, and zaleplon. Barbiturates are another older class of central nervous system depressants, although their use is now more limited because of their narrow safety margin and overdose potential. These medication groups work differently, but all can impair alertness and become dangerous when used outside medical guidance.
The clinical diagnosis covering problematic use of these substances is called sedative, hypnotic, or anxiolytic use disorder. The condition develops when continued use causes significant distress, impaired control, unsafe behavior, or problems within work, school, health, or relationships. Clinicians evaluate symptoms such as cravings, unsuccessful attempts to stop, increasing tolerance, withdrawal, neglected responsibilities, and continued use despite harmful consequences. The disorder may be classified as mild, moderate, or severe based on the number of recognized symptoms occurring within a 12-month period.
A person does not need to take medication every day or experience a dramatic crisis before treatment becomes appropriate. Someone may use sleeping medication only at night but become unable to sleep without it or repeatedly take more than prescribed. Another person may use sedatives during stressful situations, combine them with alcohol, or seek medication from several sources. A complete assessment considers the entire pattern rather than making a diagnosis based only on the medication name or prescribed dosage.
There is no single cause of sedative or hypnotic addiction. Risk may be influenced by genetics, family history, medication duration, dosage, previous substance use, trauma, chronic stress, anxiety, depression, insomnia, and access to prescriptions. Some people begin with a medically appropriate prescription but gradually increase the dosage because the medication no longer produces the same relief. Others use medication obtained from friends, relatives, online sellers, or multiple healthcare providers.
Sleep problems can become especially closely connected to hypnotic use. Someone who repeatedly struggles to fall asleep may become anxious as bedtime approaches and begin believing that sleep is impossible without medication. This expectation can reinforce nightly use even when the medication is producing daytime impairment, memory problems, or reduced sleep quality. Treatment may need to address both the medication pattern and the behaviors, thoughts, schedules, or mental health symptoms contributing to insomnia.
Anxiety and trauma symptoms may also reinforce sedative use. A medication may appear to provide immediate relief from panic, intrusive memories, emotional distress, social discomfort, or overwhelming thoughts. The relief is temporary, and repeated reliance on medication can prevent the development of more sustainable coping strategies. As tolerance and withdrawal develop, someone may begin using primarily to avoid discomfort rather than to treat the original condition.
Sedative addiction may develop gradually, and its early signs can resemble exhaustion, depression, stress, or expected medication side effects. Someone may continue meeting certain responsibilities while privately worrying about running out, taking extra doses, or hiding how much medication they use. Partners, relatives, friends, or coworkers may notice changes in memory, coordination, alertness, mood, or reliability. A qualified assessment is necessary because no single symptom proves that someone has a substance use disorder.
Common warning signs may include:
Physical signs may include unusual drowsiness, slurred speech, poor coordination, confusion, slowed reactions, memory gaps, or repeated falls. Some people appear intoxicated, while others seem outwardly functional but experience severe anxiety whenever a dose is late. Behavioral signs can include secrecy, social withdrawal, changing prescribers, unexplained financial problems, or combining several medications. The pattern becomes especially concerning when use continues despite clear evidence that it is affecting safety, health, relationships, or daily responsibilities.
Prescription sedative and tranquilizer misuse affects millions of people in the United States. The 2024 National Survey on Drug Use and Health estimated that 4.6 million people aged 12 or older misused prescription tranquilizers or sedatives during the previous year. This represented approximately 1.6% of the population aged 12 or older, including about 3.8 million adults aged 26 or older. The survey also estimated that approximately 2.1 million people had a past-year tranquilizer or sedative use disorder.
Young adult misuse has declined in recent years, but the issue remains clinically important. Among adults ages 18 to 25, the percentage reporting past-year prescription tranquilizer or sedative misuse decreased from 2.7% in 2021 to 1.6% in 2024. That still represented approximately 571,000 young adults during 2024. These statistics include a wide range of patterns and do not capture every person who develops physical dependence while following a legitimate prescription.
Physical dependence occurs when the brain and body adapt to regular exposure and produce symptoms when a medication is reduced, delayed, or stopped. Dependence can develop even when someone takes a prescribed medication exactly as instructed. Addiction more commonly involves cravings, compulsive behavior, impaired control, unsafe use, or continuing despite serious harm. Someone may experience physical dependence, addiction, medication misuse, or a combination of these concerns.
This distinction is important because a biological response to medication should not be treated as evidence of dishonesty or personal failure. A person taking medication for severe anxiety, insomnia, seizures, or another medical condition may become physically dependent without engaging in compulsive behavior. Dependence still requires careful medical management because suddenly stopping certain sedatives can produce dangerous withdrawal reactions. A clinical evaluation can determine whether the primary issue involves dependence, addiction, an undertreated condition, or several overlapping concerns.
LGBTQIA+ adults may experience stress related to discrimination, identity concealment, family rejection, harassment, relationship violence, housing insecurity, or negative healthcare encounters. Sexual orientation and gender identity do not cause addiction, and affirming treatment should never present identity as something that needs to be corrected. These experiences may nevertheless influence anxiety, trauma symptoms, insomnia, social isolation, and a person’s willingness to trust treatment providers. Rainbow Hill Recovery provides an affirming environment where relevant identity-related experiences can be discussed without judgment or stereotyping.
A client may also worry that discussing medication dependence will cause a provider to dismiss legitimate anxiety, sleep, pain, or mental health concerns. Transgender and gender-diverse clients may have questions about coordinating psychiatric care with hormone therapy or other medical treatment. Respectful care considers the client’s complete medication list, physical health, identity, relationships, and treatment goals. Clients should be able to discuss sedative use honestly without being misgendered or asked to hide important parts of themselves.
Tolerance develops when repeated exposure causes the same dose to produce a weaker or shorter effect. Someone may begin taking an additional pill, using medication earlier in the day, or combining it with alcohol or another drug. Tolerance does not automatically establish an addiction, but it may increase dependence, impairment, overdose risk, and the likelihood of unsafe dosage changes. Medication adjustments should always be discussed with the prescribing professional rather than attempted independently.
Escalation can be difficult to recognize when it develops slowly. A person who originally used medication during occasional panic attacks may begin taking it before every stressful event and eventually use it throughout the day. Someone prescribed a sleep medication may begin taking it earlier, repeating the dose during the night, or using it during daytime stress. Treatment helps identify how these routines developed and what alternatives are needed to support sleep, emotional regulation, and daily functioning.
Nonbenzodiazepine sleep medications may cause unusual activities while a person is not fully awake. Reported complex sleep behaviors include sleepwalking, driving, preparing food, or performing other activities without remembering them afterward. The FDA required boxed warnings for certain Z-drugs after reports of serious injuries and deaths related to these behaviors. These events can occur even when the medication is taken as directed and may happen after a single dose.
Someone who experiences a complex sleep behavior should contact a healthcare professional promptly and avoid independently taking another dose. Other concerns can include next-day drowsiness, impaired driving, dizziness, memory problems, and reduced coordination. Alcohol and other central nervous system depressants may increase impairment and create additional risks. Treatment planning should review the complete medication and substance-use pattern rather than focusing only on nighttime use.
Sedative withdrawal can become medically serious, especially when it involves benzodiazepines or barbiturates. Symptoms may include severe anxiety, agitation, insomnia, sweating, tremors, nausea, sensitivity to light or sound, confusion, hallucinations, or seizures. The FDA warns that abruptly stopping benzodiazepines or reducing the dosage too rapidly can produce life-threatening withdrawal reactions. The American Society of Addiction Medicine advises that people who have taken benzodiazepines regularly for longer than one month generally should not discontinue them suddenly.
A taper must be individualized according to the medication, dosage, duration, medical history, other substances, and the person’s response to dose reductions. Some tapers can be completed in outpatient medical care, while others require a more intensive or closely monitored setting. Rainbow Hill Recovery’s outpatient behavioral programs are intended for clients who are medically stable enough to participate safely. Anyone experiencing active withdrawal, hallucinations, seizures, severe confusion, or another urgent symptom requires immediate medical evaluation before routine outpatient treatment.
Treatment begins with a detailed assessment of medications, prescriptions, withdrawal history, mental health, physical health, trauma, alcohol or drug use, relationships, and living conditions. The assessment helps determine whether medically supervised tapering or another level of care is required before outpatient behavioral treatment begins. It also identifies what the medication has been helping the client manage, such as anxiety, insomnia, panic, grief, or traumatic stress. A personalized plan can then address both substance-related behaviors and the concerns contributing to continued use.
Behavioral therapy may help clients identify automatic thoughts, triggers, environments, and routines connected to sedative use. Cognitive and behavioral strategies can support healthier responses to insomnia, anxiety, cravings, and stress. Dialectical Behavior Therapy may strengthen mindfulness, emotional regulation, distress tolerance, and interpersonal skills. Trauma-informed care may help clients address painful experiences without shame, confrontation, or forced disclosure.
Treatment for hypnotic misuse may also include behavioral strategies for improving sleep. Clients can examine irregular sleep schedules, daytime sleeping, nighttime anxiety, screen use, environmental disruptions, and beliefs about being unable to sleep without medication. Changes are introduced gradually and should be coordinated with medical professionals when prescription medication is involved. The goal is to support healthier sleep while reducing reliance on unsafe or uncontrolled sedative use.
Sedatives can suppress alertness, coordination, and breathing, particularly at high doses or when several depressants are combined. Mixing benzodiazepines or other sedatives with opioids can cause profound sedation, respiratory depression, coma, and death. Alcohol can intensify sedation and further impair breathing, memory, balance, and judgment. The FDA requires prominent warnings about these risks and recommends that patients disclose all medications and substances to their healthcare providers.
Possible overdose signs include extreme drowsiness, confusion, slowed or stopped breathing, weak pulse, loss of coordination, bluish or gray skin, or an inability to wake the person. A suspected overdose is always a medical emergency, even when the exact medication or amount is unknown. Call 911 immediately and remain with the person until emergency responders arrive. Naloxone should be administered when available if opioid exposure may be involved, although it will not reverse sedation caused solely by a non-opioid sedative.
Rainbow Hill Recovery offers Partial Hospitalization, Intensive Outpatient, Outpatient, and Virtual IOP services for adults who are clinically appropriate for outpatient care. PHP provides the greatest degree of outpatient structure, while IOP combines regular therapeutic programming with more independence outside treatment hours. OP may be suitable for clients who need flexible continuing care or are transitioning from a more intensive program. Virtual IOP provides structured remote support when telehealth is appropriate for the client’s safety, privacy, technology access, and living environment.
Depending on the treatment plan, services may include individual therapy, group therapy, psychiatric support, case management, relapse-prevention education, and practical skill development. Program placement considers medical stability, withdrawal risk, substance-use severity, mental health symptoms, responsibilities, living conditions, and available support. Clients who require acute withdrawal management or medical stabilization should complete that care before entering routine outpatient programming. Once stable, they can focus on cravings, anxiety, sleep, trauma, relationships, and long-term recovery.
Sedative-related triggers may include panic symptoms, sleeplessness, work pressure, medical appointments, relationship conflict, pharmacies, medication bottles, or fear of withdrawal. Relapse-prevention planning helps clients identify personal warning signs and choose specific actions before cravings become overwhelming. A practical plan may include contacting a treatment provider, using learned coping skills, following medication safeguards, attending therapy, and removing unused prescriptions from the home. Practicing these responses during treatment can make them easier to use in everyday life.
For LGBTQIA+ clients, relapse triggers may also involve rejection, discrimination, misgendering, isolation, or returning to an environment where they do not feel safe. Affirming support can reduce the pressure to explain or defend one’s identity while working on recovery. Partners, supportive relatives, chosen family members, peers, therapists, and community resources may all become part of a stable support network. Recovery becomes more sustainable when clients have several sources of connection and accountability rather than relying on willpower alone.
Rainbow Hill Recovery’s aftercare services help clients continue applying recovery skills after completing a more structured stage of treatment. Continuing care may include therapy, support groups, check-ins, relapse-prevention education, practical resources, and connections to supportive environments. These services provide opportunities to address renewed anxiety, insomnia, cravings, relationship changes, and medication concerns before they become larger problems. Aftercare supports greater independence while helping clients remain connected to care and community.
Rainbow Hill Recovery provides LGBTQIA+-affirming outpatient care for adults who need help addressing sedative or hypnotic use alongside anxiety, insomnia, trauma, relationships, and other mental health concerns. Our multiple treatment programs allow care intensity to be matched to each client’s medical stability, symptoms, responsibilities, strengths, and recovery goals. Clients may receive individual and group therapy, trauma-informed and affirmative care, psychiatric support, relapse-prevention education, case management, and personalized continuing-care planning. Treatment is designed to address the complete person rather than focusing only on medication use.
Someone does not need to wait for an overdose, accident, damaged relationship, job loss, or another serious consequence before asking for help. An assessment can clarify whether the primary concern is misuse, physical dependence, addiction, an underlying mental health condition, or several overlapping issues. Rainbow Hill Recovery combines structured outpatient programming with affirming care, psychiatric support, trauma-informed therapy, practical recovery education, and continuing community connection. Call (310) 341-4887 to speak with our Los Angeles team about sedative or hypnotic addiction treatment and the next appropriate step.
Joie Gyondla serves as Rainbow Hill Recovery’s Clinical Support Coordinator, bringing compassion, empathy, and a genuine commitment to supporting every client who walks through our doors. With a background in recovery support, Joie understands the importance of creating a welcoming, organized, and affirming environment where individuals feel seen, valued, and supported throughout their treatment journey.
Working closely with both clients and the clinical team, Joie helps ensure that each person’s experience is as seamless as possible, providing encouragement, guidance, and practical support every step of the way. Her calm presence and dedication to helping others foster a sense of safety and connection that allows clients to focus on what matters most: their recovery.
Joie believes that healing begins with compassion and that even the smallest acts of kindness can make a lasting difference. She is proud to be part of the Rainbow Hill Recovery team, helping create a community where every individual is empowered to build a healthier, more authentic future.
Co-Founder of the LGBTQ+ Association for Addiction and Mental Health Professionals Clinical Outreach Specialist for Rainbow Hill Recovery LGBTQ Sensitivity Training Consultant
Steven Buffin-Stewart is the Case Manager at Rainbow Hill Recovery, with over five years of experience in substance use and mental health treatment. A CADC ll professional in recovery themselves, Steven combines clinical knowledge with lived experience to provide compassionate, coordinated care and foster inclusive, affirming spaces where clients feel supported, empowered, and hopeful in their healing journey.
Steven Buffin-Stewart is the Program and Case Manager at Rainbow Hill Recovery, with over five years of experience in substance use and mental health treatment. A CADC ll professional in recovery themselves, Steven combines clinical knowledge with lived experience to provide compassionate, coordinated care and foster inclusive, affirming spaces where clients feel supported, empowered, and hopeful in their healing journey.
Janae Borrego serves as Rainbow Hill Recovery’s Cross-Cultural Relations Officer and Outpatient Therapist, where she combines her clinical expertise with a deep commitment to fostering an inclusive, culturally responsive environment for every client. Her ability to understand, appreciate, and navigate diverse cultural perspectives has made her an invaluable leader as Rainbow Hill continues to grow and evolve.
In her role, Janae works to strengthen cultural understanding throughout the organization, ensuring that clients, families, and staff feel respected, heard, and represented. She provides ongoing guidance on cultural sensitivity and inclusive practices while helping shape programs that honor the unique identities, backgrounds, and lived experiences of those we serve.
As an Outpatient Therapist, Janae is dedicated to helping clients navigate recovery, mental health, and life’s challenges with compassion, authenticity, and evidence-based care. She believes that meaningful healing begins when individuals feel safe to show up as their authentic selves and receive support that acknowledges the whole person.
Janae is passionate about creating spaces where diversity is celebrated, connection is strengthened, and every individual has the opportunity to heal and thrive. Her leadership continues to advance Rainbow Hill Recovery’s mission of providing affirming, trauma-informed care that meets the evolving needs of the communities we serve.
With over a decade of experience in addiction recovery, Andrew is passionate about helping individuals reclaim their lives and find lasting healing. As Co-founder and Director of Rainbow Hill Recovery, he is dedicated to creating a supportive environment that fosters hope, resilience, and transformation.
Joey Bachrach is the Co-Founder and CEO of Rainbow Hill Recovery, an LGBTQ-affirming mental health and substance use treatment center in Los Angeles. Drawing from both professional leadership and lived recovery experience, Joey is dedicated to creating safe, inclusive spaces where individuals are fully seen, affirmed, and supported on their healing journey.